Jacky Vonderscher

Jacky Vonderscher, Ph.D., founded ENYO Pharma SAS in 2014 and serves as its President. Vonderscher has been a Consultant for Biotech companies since 2013.Vonderscher is a Co-Inventor on the patents of Mycophenolic Acid Sodium salt (Myfortic(R)) and of Everolimus (Certican(R) and Affinitor(R)). He served as Senior Vice President and Head of Translation Research Sciences at Roche in USA and Switzerland from 2010 to 2012.

He also served as Senior Vice President and Head of Molecular Medicine Labs at Roche from 2008 to 2010. He is a Senior executive with a broad R&D experience in the pharmaceutical industry. He has different leading positions in R&D at Sandoz, Novartis from 1979 to 2008 and finally at Roche where he was lately Global Head of Translational Research Sciences. His work was acknowledged in 1995 for the successful development of Sandimmune Neoral(R). He serves as an Independent Director of ObsEva SA and ENYO Pharma SAS.

Jacky Vonderscher is the Founder, President and CEO at ENYO Pharma, based in Switzerland, Europe. With a background in Biotechnology, Jacky Vonderscher has a rich history of leadership and innovation.Jacky Vonderscher studied PhD Biochemistry at University of Geneva. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.